Project Grant HT94252410094
Award Date
2/15/24
Completion Date
2/14/27
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Americo Miranda, San Juan, PR 00935, Puerto Rico
Similar Awards
The University of Puerto Rico Medical Sciences Campus will receive $1.3 million under a three-year Project Grant award from the Defense Health Agency to support translational development of MBQ-167 as a targeted therapy for metastatic breast cancer. Through the Military Medical Research and Development program (CFDA 12.420), the award will fund applied and advanced biomedical research efforts aimed at transforming healthcare for service members and the general public. Specifically, the...
This federal Block Grant award of $494,625 from the Department of Defense's Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) supports the acquisition of a laser scanning confocal microscope at the University of Puerto Rico Medical Sciences Campus (UPR-MSC). The award, effective September 1, 2024, will enable UPR-MSC, a minority-serving and Hispanic-serving academic institution, to enhance its biomedical research capabilities over the 12-month performance...
The University of Pittsburgh was awarded a $925,680 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2027 targeting the IGFBP2-SRC signaling axis to block metastatic spread and tumor-mesothelial crosstalk. Through this research, the University aims to develop medical solutions for the battlefield by investigating approaches to prevent cancer metastasis. The Military...
This $1,535,039 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development Program (CFDA 12.420) supports research conducted by Wake Forest University Health Sciences (WFUHS) to study how the breast tissue microbiota regulates immune checkpoint blockade therapy responsiveness in triple-negative breast cancer. The research aims to advance scientific understanding and develop new treatment approaches for this aggressive form of breast cancer that...
The Regents of the University of California, San Francisco will receive $4.8 million over four years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to reveal and target multiple pathways of breast cancer metastasis, with the goal of transforming healthcare for service members and the public through innovative biomedical research focused on investigating medical...
The federal Project Grant award of $1,700,000.00 was provided by the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to the University of Miami's Office of Research Administration - School of Medicine Division on September 15, 2024, with a completion date of September 14, 2026. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the...
The U.S. Department of Defense, through the Military Medical Research and Development (CFDA 12.420) program, awarded a $161,000 Project Grant to Duke University to conduct research on "Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes." The grant, with a performance period from April 1, 2025, to March 31, 2026, will support advanced biomedical research focused on transforming healthcare for military service members and the...
This federal Project Grant award from the Department of Defense's Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) provides $648,927 to the University of Puerto Rico to acquire a Physical Properties Measurement System. This system will support research and training in quantum materials and transformative devices at the University of Puerto Rico's Research and Development Center Division. The award has a performance period from September 1, 2024 to August 31,...
The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...